Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|December 1, 1994
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemiaC H Weaver, R A Clift, H J Deeg, et al.
Bone Marrow Transplantation|March 9, 2011
Prognostic value of response after upfront therapy for acute GVHDR M Saliba, D R Couriel, S Giralt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Bone Marrow Transplantation|July 1, 1994
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaH M Kantarjian, M Talpaz, B Andersson, et al.
Bone Marrow Transplantation|October 16, 2002
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentationD R Couriel, G Z Beguelin, S Giralt, et al.
Bone Marrow Transplantation|April 1, 1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicityK van Besien, J Tabocoff, M Rodriguez, et al.
Leukemia|August 26, 2016
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosisH Landau, M Smith, C Landry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimensJ P Radich, J E Sanders, C D Buckner, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancerF Gutierrez-Delgado, L A Holmberg, H Hooper, et al.
Bone Marrow Transplantation|September 1, 1994
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantationD Przepiorka, C Ippoliti, S Giralt, et al.
Pageof 21